AP20187
AP20187 (B/B Homodimerizer) is a cell-permeable ligand used to dimerize FK506-binding protein (FKBP) fusion proteins and initiate biological signaling cascades and gene expression or disrupt protein-protein interactions.
Product Specifications
CAS Number
195514-80-8
Product Name Alternative
B/B Homodimerizer
UNSPSC
12352005
Target
FKBP
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/AP20187.html
Purity
99.88
Solubility
DMSO : ≥ 57 mg/mL|Ethanol : ≥ 71.43 mg/mL
Smiles
COC1=C(OC)C=C(CC[C@H](C2=CC=CC(OCC(NCC(CN(C)C)CNC(COC3=CC=CC([C@H](OC([C@H]4N(C([C@@H](CC)C5=CC(OC)=C(OC)C(OC)=C5)=O)CCCC4)=O)CCC6=CC(OC)=C(OC)C=C6)=C3)=O)=O)=C2)OC([C@@H]7CCCCN7C([C@H](C8=CC(OC)=C(OC)C(OC)=C8)CC)=O)=O)C=C1
Molecular Formula
C82H107N5O20
Molecular Weight
1482.75
References & Citations
[1]Ahmed S, et al. Photocleavable dimerizer for the rapid reversal of molecular trap antagonists. J Biol Chem. 2014 Feb 21;289 (8) :4546-52.|[2]Lin W, et al. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci. 2013 Apr 3;33 (14) :5980-91.|[3]Haas ME, et al. The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia. Circulation. 2016 Jul 5;134 (1) :61-72.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15187404 1 Vial
Lentiviral mouse Myo18b shRNA (UAS) - Lentiviral mouse Myo18b shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
GTR15242096 1 Vial
Lentiviral mouse Gyg shRNA (UAS) - Lentiviral mouseGyg shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details